The purposes of this study are:
1. To provide evidence from a randomized controlled trial that InterStim Therapy provides
better relief of symptoms of OAB than standard medical treatments in current use.
2. To fulfill the requirements of the FDA-mandated post-approval study of the safety of the
tined lead using a minimally invasive approach.